OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.As of 14 Jun 2026, ONESOURCE SPECL PHARMA L share price is ₹1,612.50. The stock opened at ₹1,655.10, compared to its previous close of ₹1,651.40. During today's trading session, ONESOURCE SPECL PHARMA L share price moved in the range of ₹1,591.80 to ₹1,670.00, with an average price of ₹1,630.90 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,591.80 and a high of ₹1,670.00. On the performance front, ONESOURCE SPECL PHARMA L share price has declined by 1.39% over the last six months and is down 18.42% on a year-on-year basis.
The market capitalization of ONESOURCE SPECL PHARMA L is ₹18,497 Crs, with a P/E ratio of -250.5 and a dividend yield of 0.00%.